Tissue Repair Ltd (AU:TRP) — Market Cap & Net Worth
Market Cap & Net Worth: Tissue Repair Ltd (TRP)
Tissue Repair Ltd (AU:TRP) has a market capitalization of $4.28 Million (AU$6.05 Million) as of June 21, 2026. Listed on the AU stock exchange, this Australia-based company holds position #28854 globally and #1594 in its home market, demonstrating a -4.76% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tissue Repair Ltd's stock price AU$0.10 by its total outstanding shares 60464843 (60.46 Million). Review Tissue Repair Ltd debt and liabilities to assess the company's total debt and financial obligations.
Tissue Repair Ltd Market Cap History: 2021 to 2026
Tissue Repair Ltd's market capitalization history from 2021 to 2026. Data shows change from $23.32 Million to $4.28 Million (-34.47% CAGR).
Tissue Repair Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tissue Repair Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.26x
Tissue Repair Ltd's market cap is 6.26 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $23.32 Million | $152.64K | -$915.23K | 152.76x | N/A |
| 2022 | $9.84 Million | $171.92K | -$6.84 Million | 57.24x | N/A |
| 2023 | $9.41 Million | $3.08K | -$4.17 Million | 3059.88x | N/A |
| 2024 | $11.98 Million | $152.24K | -$4.14 Million | 78.69x | N/A |
| 2025 | $16.47 Million | $2.63 Million | -$4.24 Million | 6.26x | N/A |
Competitor Companies of TRP by Market Capitalization
Companies near Tissue Repair Ltd in the global market cap rankings as of June 21, 2026.
Key companies related to Tissue Repair Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #220 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #445 globally with a market cap of $62.84 Billion USD.
- UCB SA (BR:UCB): Ranked #547 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #571 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #220 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $451.63 |
| #445 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $62.84 Billion | $609.94 |
| #547 | UCB SA | BR:UCB | $49.68 Billion | €249.70 |
| #571 | Argen-X | BR:ARGX | $47.14 Billion | €773.80 |
Tissue Repair Ltd Historical Marketcap From 2021 to 2026
Between 2021 and today, Tissue Repair Ltd's market cap moved from $23.32 Million to $ 4.28 Million, with a yearly change of -34.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$4.28 Million | -74.03% |
| 2025 | AU$16.47 Million | +37.50% |
| 2024 | AU$11.98 Million | +27.27% |
| 2023 | AU$9.41 Million | -4.35% |
| 2022 | AU$9.84 Million | -57.80% |
| 2021 | AU$23.32 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 21st, 2026 the market cap of Tissue Repair Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.28 Million USD |
| MoneyControl | $4.28 Million USD |
| MarketWatch | $4.28 Million USD |
| marketcap.company | $4.28 Million USD |
| Reuters | $4.28 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Tissue Repair Ltd
Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. The company utilizes Glucoprime technology, an immunogenic active pharmaceutical ingredient that activates macrophages and stimulates immune response for wound healing and skin regeneration. It develops TR-987, a topical … Read more